InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: jessellivermore post# 92108

Wednesday, 09/14/2016 11:53:49 PM

Wednesday, September 14, 2016 11:53:49 PM

Post# of 425926
Thank you. I'll be as cautious as I should be with a small bio stock. I am having trouble accepting the certainty of a patent infringement with CaPre though, as many of you guys suggest. Amarin overcame a lot of patent concerns and regulatory hurdles to get where they are...not bad by the way...congrats to all you longs. I'm comfortable, at this point, with the little dog chasing the big dog's tale: The big dog is fat from too much fish! :)

Neptune has a long history of manufacturing krill, has many patents in their own right, and has won several international patent disputes in the last few years to defend their business. Yes, the science is light at this point, but there is not much reason to believe it won't be deepening soon. Everything is new/young early on, yes? Just because there isn't much evidence does not mean it doesn't work as good as, or even better, than Vascepa or Lovaza. We shall see in a few years.

Messages posted by individuals may be misleading, deceptive, or in error. If you disagree with a posting, feel free to voice your opinion. It is the policy of iHub to allow our members to freely discuss issues in a free and open manner

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News